131 related articles for article (PubMed ID: 6124398)
1. Comparative metabolism of 1,2,4-trichlorobenzene in the rat and rhesus monkey.
Lingg RD; Kaylor WH; Pyle SM; Kopfler FC; Smith CC; Wolfe GF; Cragg S
Drug Metab Dispos; 1982; 10(2):134-41. PubMed ID: 6124398
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of 1,2,4-trichlorobenzene in rats: examination of thiol formation.
Bakke JE; Huwe JK; Mulford DJ; Bergman A
Xenobiotica; 1992 Feb; 22(2):199-210. PubMed ID: 1632109
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of 1,2,3,4-, 1,2,3,5-, and 1,2,4,5-tetrachlorobenzene in the squirrel monkey.
Schwartz H; Chu I; Villeneuve DC; Benoit FM
J Toxicol Environ Health; 1987; 22(3):341-50. PubMed ID: 3682021
[TBL] [Abstract][Full Text] [Related]
4. Route-dependent comparative metabolism of [14C]toluene 2,4-diisocyanate and [14C]toluene 2,4-diamine in Fischer 344 rats.
Timchalk C; Smith FA; Bartels MJ
Toxicol Appl Pharmacol; 1994 Feb; 124(2):181-90. PubMed ID: 8122263
[TBL] [Abstract][Full Text] [Related]
5. Species differences in the metabolism and disposition of spironolactone.
Karim A; Kook C; Zitzewitz DJ; Zagarella J; Doherty M; Campion J
Drug Metab Dispos; 1976; 4(6):547-55. PubMed ID: 11976
[TBL] [Abstract][Full Text] [Related]
6. Comparative metabolism of the renal carcinogen 1,4-dichlorobenzene in rat: identification and quantitation of novel metabolites.
Klos C; Dekant W
Xenobiotica; 1994 Oct; 24(10):965-76. PubMed ID: 7900412
[TBL] [Abstract][Full Text] [Related]
7. Enterohepatic circulation of the mercapturic acid and cysteine conjugates of propachlor.
Bakke JE; Rafter J; Larsen GL; Gustafsson JA; Gustafsson BE
Drug Metab Dispos; 1981; 9(6):525-8. PubMed ID: 6120810
[TBL] [Abstract][Full Text] [Related]
8. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
9. Orally active inhibitors of human leukocyte elastase. II. Disposition of L-694,458 in rats and rhesus monkeys.
Vincent SH; Painter SK; Luffer-Atlas D; Karanam BV; McGowan E; Cioffe C; Doss G; Chiu SH
Drug Metab Dispos; 1997 Aug; 25(8):932-9. PubMed ID: 9280401
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
Prakash C; Soliman V
Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
[TBL] [Abstract][Full Text] [Related]
11. N-acetyl-S-(1,2,2-trichlorovinyl)-L-cysteine and 2,2,2-trichloroethanol: two novel metabolites of tetrachloroethene in humans after occupational exposure.
Birner G; Rutkowska A; Dekant W
Drug Metab Dispos; 1996 Jan; 24(1):41-8. PubMed ID: 8825189
[TBL] [Abstract][Full Text] [Related]
12. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
[TBL] [Abstract][Full Text] [Related]
13. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
Prakash C; Cui D
Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
[TBL] [Abstract][Full Text] [Related]
14. The metabolism of zomepirac sodium. I. Disposition in laboratory animals and man.
Grindel JM; O'Neill PJ; Yorgey KA; Schwartz MH; McKown LA; Migdalof BH; Wu WN
Drug Metab Dispos; 1980; 8(5):343-8. PubMed ID: 6107233
[TBL] [Abstract][Full Text] [Related]
15. Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs.
Meuldermans W; Hendrickx J; Lauwers W; Swysen E; Hurkmans R; Knaeps F; Woestenborghs R; Heykants J
Drug Metab Dispos; 1984; 12(6):772-81. PubMed ID: 6150829
[TBL] [Abstract][Full Text] [Related]
16. Role of 2,3,5-trichlorophenyl methyl sulfone, a metabolite of 1,2,4-trichlorobenzene, in the induction of hepatic microsomal drug-metabolizing enzymes by 1,2,4-trichlorobenzene in rats.
Kato Y; Yamada S; Sato M; Kimura R
Toxicol Appl Pharmacol; 1993 Oct; 122(2):214-21. PubMed ID: 8212004
[TBL] [Abstract][Full Text] [Related]
17. Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys.
Colletti AE; Krieter PA
Drug Metab Dispos; 1994; 22(2):183-8. PubMed ID: 8013272
[TBL] [Abstract][Full Text] [Related]
18. 3,3',4,4'-tetrachloroazobenzene absorption, disposition, and metabolism in male Fischer 344 rats.
Pillai UA; Ziegler TL; Wang DX; Kattnig MJ; McClure T; Liebler DC; Mayersohn M; Sipes IG
Drug Metab Dispos; 1996 Feb; 24(2):238-44. PubMed ID: 8742237
[TBL] [Abstract][Full Text] [Related]
19. Disposition and pharmacokinetics of naltrexone after intravenous and oral administration in rhesus monkeys.
Reuning RH; Ashcraft SB; Wiley JN; Morrison BE
Drug Metab Dispos; 1989; 17(6):583-9. PubMed ID: 2575491
[TBL] [Abstract][Full Text] [Related]
20. Influence of a purified diet and route of administration on the metabolism and disposition of estradiol in B6C3F1 mice.
Fullerton FR; Greenman DL; Young JF
Drug Metab Dispos; 1987; 15(5):602-7. PubMed ID: 2891474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
